Ignite Creation Date:
2025-12-25 @ 4:47 AM
Ignite Modification Date:
2026-01-24 @ 8:04 PM
Study NCT ID:
NCT06655818
Status:
TERMINATED
Last Update Posted:
2025-03-03
First Post:
2024-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM
Sponsor:
Organization: